ARCH Venture Partners targets $3 billion raise for latest fund
ARCH Venture Partners, one of highest-profile names in biotech investing, has outlined plans for another $3 billion fund. The new fund — its 14th — would be one of the largest batches of venture capital raised in ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.